Showing results (201-210 of 266) with videos related to

Sort By:
Pageof 27
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1993
Comparative outcome of heart-lung and lung transplantation for pulmonary hypertensionA Chapelier, P Vouhé, P Macchiarini, et al.
The European Respiratory Journal|September 19, 2008
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertensionB Degano, A Yaïci, J Le Pavec, et al.
The American Review of Respiratory Disease|December 1, 1991
Increased lung clearance of 99mTcDTPA in allograft lung rejection. The Paris-Sud Lung Transplant GroupP A Herve, D Silbert, J Mensch, et al.
Gut|January 1, 1994
Duodenal bacterial overgrowth during treatment in outpatients with omeprazoleM Fried, H Siegrist, R Frei, et al.
Transplantation|June 15, 1994
Emergence of inflammatory alveolar macrophages during rejection or infection after lung transplantationI Frachon, M Fattal-German, A Magnan, et al.
The European Respiratory Journal|January 3, 2006
Occult alveolar haemorrhage in pulmonary veno-occlusive diseaseA Rabiller, X Jaïs, A Hamid, et al.
The European Respiratory Journal|March 3, 2009
Fenfluramine-like cardiovascular side-effects of benfluorexK Boutet, I Frachon, Y Jobic, et al.
Lancet (London, England)|June 24, 2008
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trialN Galiè, Lj Rubin, Mm Hoeper, et al.
The Journal of Clinical Investigation|October 17, 2001
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertensionS Eddahibi, M Humbert, E Fadel, et al.
The European Respiratory Journal|October 2, 2010
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertensionN Gambaryan, F Perros, D Montani, et al.
Pageof 27